Market cap
$6,839 Mln
Revenue (TTM)
$2,590 Mln
P/E Ratio
42.5
P/B Ratio
1
Div. Yield
0 %
Stock Range
Today’s Range
52 Week Range
Liquidity
Fundamentals
-
Net Profit (TTM)
$0 Mln
-
ROE
0 %
-
ROCE
-- %
-
Industry P/E
44.07
-
EV/EBITDA
15.1
-
Debt to Equity
0.1
-
Book Value
$--
-
EPS
$6.1
-
Face value
--
-
Shares outstanding
5,061,038
10 Years Aggregate
CFO
$3,324.47 Mln
EBITDA
$4,405.61 Mln
Net Profit
$6,268.10 Mln
Performance
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Bio-Rad Laboratories
| -- | -6.1 | -- | 4.0 | -11.4 | -16.3 | 6.2 |
|
BSE Sensex
| -11.1 | -2.1 | -8.9 | -7.5 | 6.6 | 9.1 | 11.4 |
|
S&P Small-Cap 600#
| -5.8 | -5.3 | -13.7 | -6.3 | 5.3 | 3.0 | 5.5 |
|
Company
|
2024
|
2023
|
2022
|
2021
|
2020
|
2019
|
2018
|
|---|---|---|---|---|---|---|---|
|
Bio-Rad Laboratories
| 1.5 | -20.8 | -44.0 | 25.9 | 55.0 | 60.7 | -3.4 |
|
S&P Small-Cap 600
| 7.0 | 13.9 | -17.4 | 25.3 | 9.6 | 20.9 | -9.7 |
|
BSE Sensex
| 8.1 | 18.7 | 4.4 | 22.0 | 15.8 | 14.4 | 5.9 |
Essential Checks
View DetailsIs there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
Financials
View DetailsKey Ratios
View Details
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Peers
View DetailsCompany |
Price ($) | Market Cap ($ Mln) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
Bio-Rad Laboratories
|
260.0 | 6,838.7 | 2,589.9 | 168.8 | 21.4 | 2.5 | 42.5 | 1.0 |
| 7.8 | 5,441.6 | 6,552.2 | -551.4 | -4.3 | -9.9 | -- | 1.0 | |
| 43.5 | 6,586.8 | 3,458.5 | -10.3 | 1.9 | -0.5 | -- | 2.7 | |
| 23.9 | 3,938.0 | 2,808.1 | 67.7 | 6.8 | 2.2 | 59 | 1.3 | |
| 142.7 | 7,950.8 | 551.4 | -189.3 | -15.6 | -26.3 | -- | 11.7 | |
| 115.0 | 3,839.6 | 787.9 | -27.8 | -2.7 | -19.6 | -- | 24.6 | |
| 94.6 | 6,124.5 | 1,546.2 | 279.0 | 15.0 | 23.9 | 22.5 | 5.0 | |
| 178.4 | 9,347.9 | 1,558.5 | 76.3 | 19.1 | 9.5 | 44.1 | 11.8 | |
| 323.5 | 12,653.3 | 1,454.3 | 171.1 | 11.1 | 12.1 | 74.1 | 8.6 | |
| 105.9 | 6,538.2 | 763.3 | 51.4 | 11.6 | 2.5 | 127.4 | 3.3 |
Shareholding Pattern
View DetailsAbout Bio-Rad Laboratories
Bio-Rad Laboratories, Inc. develops, manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, Latin America, and internationally. It operates through two segments, Life Science... and Clinical Diagnostics. The Life Science segment develops, manufactures, and markets instruments, systems, reagents, and consumables to separate, purify, characterize, and quantify biological materials, including cells, proteins, and nucleic acids used in research and biopharmaceutical laboratory environments, as well as for biopharmaceutical manufacturing, quality control process, food safety, and science education applications. This segment serves universities and medical schools, industrial research organizations, government agencies, pharmaceutical manufacturers, biotechnology companies, food producers, and testing laboratories. Its Clinical Diagnostics segment designs, manufactures, markets, and supports diagnostic test systems, informatics systems, test kits, and specialized quality controls for clinical, hospital, diagnostic reference, and transfusion and physician office laboratories, as well as software. The company offers its products through its direct commercial organization, as well as through distributors, agents, brokers, and resellers. Bio-Rad Laboratories, Inc. was founded in 1952 and is headquartered in Hercules, California. Address: 1000 Alfred Nobel Drive, Hercules, CA, United States, 94547 Read more
-
Chairman, CEO, President & Principal Financial Officer
Mr. Norman D. Schwartz
-
Chairman, CEO & President
Mr. Norman D. Schwartz
-
Headquarters
Hercules, CA
-
Website
Value Research Ratings
Our rating system has guided millions of investors in the past 20 years.
FAQs for Bio-Rad Laboratories
What is the current share price of Bio-Rad Laboratories Inc Today?
The share price of Bio-Rad Laboratories Inc is $260.00 (NYSE) as of 15-May-2026 09:46 EDT. Bio-Rad Laboratories Inc has given a return of -11.41% in the last 3 years.
What is the current PB & PE ratio of Bio-Rad Laboratories Inc?
The P/E ratio of Bio-Rad Laboratories Inc is 42.52 times as on 12-May-2026, a 4 discount to its peers’ median range of 44.07 times.
The P/B ratio of Bio-Rad Laboratories Inc is 1.00 times as on 12-May-2026, a 65 discount to its peers’ median range of 2.89 times.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
|
2025
|
--
|
--
|
|
2024
|
-4.94
|
1.39
|
|
2023
|
-14.50
|
1.06
|
|
2022
|
-3.32
|
1.25
|
|
2021
|
5.08
|
1.58
|
What is the 52 Week High and Low of Bio-Rad Laboratories Inc?
The 52-week high and low of Bio-Rad Laboratories Inc are Rs 299.45 and Rs 244.54 as of 15-May-2026.
What is the market cap of Bio-Rad Laboratories Inc?
Bio-Rad Laboratories Inc has a market capitalisation of $ 6,839 Mln as on 12-May-2026. As per SEBI classification, it is a Small Cap company.
Should I invest in Bio-Rad Laboratories Inc?
Before investing in Bio-Rad Laboratories Inc, assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.